Mosunetuzumab, a CD20xCD3 bispecific T-cell engager, in granulomatosis with polyangiitis

2025/11/20 by Ayla Nadja Stütz, Laura-Marie Lahu, Sandra Jaschinski +7 · 1 citation
Medicine · #Vasculitis and related conditions #Monoclonal and Polyclonal Antibodies Research #CAR-T cell therapy research

paper · doi:10.1016/j.ard.2025.10.026

Citations

• EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update

Cited by

• T-cell engagers mediate deep cell depletion beyond autoimmunity